Pharmacological activation of Epac1, selective enhancement of Rap1/Rac1 signaling, or targeted suppression of RhoA/ROCK during the repair phase could accelerate endothelial sealing in acute inflammatory conditions such as sepsis, acute respiratory distress syndrome, and ischemia–reperfusion injury. Here, RAPGEF3 is linked to acute respiratory distress syndrome.